Officer Director Change Filing

Liane Rae Teplitsky, Chief Operating Officer of PULSE BIOSCIENCES, INC. (PLSE), was granted 200,000 Restricted Stock Units (RSUs) and 700,000 stock options on August 8, 2026. The RSUs are contingent on receiving one share of common stock upon vesting, with vesting tied to performance-based criteria established by the Board of Directors. The stock options have a strike price of $19.06. Two-sevenths of the option shares vest over four years, while the remainder vest upon achievement of market capitalization targets between $2 billion and $5 billion, along with product revenue targets from $100 million to $330 million, contingent on continued service. All transactions were reported on a Form 4 filing dated August 28, 2026.